These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 2193615

  • 1. Plasmid-mediated 4-quinolone resistance: a real or apparent absence?
    Courvalin P.
    Antimicrob Agents Chemother; 1990 May; 34(5):681-4. PubMed ID: 2193615
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of quinolone resistance genes in a clinical isolate of quinolone-resistant MRSA.
    Kojima T, Yamagishi J, Oyamada Y, Yoshida H, Hattori H, Inoue M, Nakamura S.
    Drugs; 1995 May; 49 Suppl 2():182-4. PubMed ID: 8549296
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quinolone resistance from a transferable plasmid.
    Martínez-Martínez L, Pascual A, Jacoby GA.
    Lancet; 1998 Mar 14; 351(9105):797-9. PubMed ID: 9519952
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.
    Alarcón T, Pita J, López-Brea M, Piddock LJ.
    J Antimicrob Chemother; 1993 Oct 14; 32(4):605-9. PubMed ID: 8288502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Minimizing quinolone resistance: are the new agents more or less likely to cause resistance?
    Thomson KS.
    J Antimicrob Chemother; 2000 Jun 14; 45(6):719-23. PubMed ID: 10837422
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Major advances in antibacterial quinolone therapy.
    Neu HC.
    Adv Pharmacol; 1994 Jun 14; 29A():227-62. PubMed ID: 7826861
    [No Abstract] [Full Text] [Related]

  • 12. Quinolone resistance in Pseudomonas aeruginosa.
    Hashmi ZS, Smith JM.
    J Antimicrob Chemother; 1994 Apr 14; 33(4):881-3. PubMed ID: 8056710
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-level quinolone resistance in Pseudomonas aeruginosa.
    Piddock LJ, Panchal S, Inglis TJ, Hawkey PM.
    J Antimicrob Chemother; 1992 Aug 14; 30(2):229-31. PubMed ID: 1399933
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Quinolone resistance: a practical perspective.
    Wood CA.
    Arch Intern Med; 1993 Jan 11; 153(1):120-1. PubMed ID: 8422194
    [No Abstract] [Full Text] [Related]

  • 17. Quinolone resistance and Campylobacter species.
    Bowler IC, Connor M, Lessing MP, Day D.
    J Antimicrob Chemother; 1996 Aug 11; 38(2):315. PubMed ID: 8877548
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City.
    Durazo F, Resano F, Gonzalez MA.
    Diagn Microbiol Infect Dis; 1990 Aug 11; 13(1):71-5. PubMed ID: 2331854
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.